{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/51660"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/51660","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"The pathogenesis, progression, and treatment of neovascular age-related macular degeneration","abstract":"Age-related macular degeneration is a form of blindness that targets the macula of the eye and causes progressive vision loss. Many individuals all over the world are affected by this disease with the numbers expected to only increase in the coming years. As a result, it is critical that treatment options for this disease continue to be investigated to slow or halt the progression of disease and to hopefully one day find a cure. Currently, there are numerous treatment options available including laser therapy as well as vascular endothelial growth factor antagonists. In addition, there are human cell lines being investigated as possible study tools and future treatment options or cures. Although no cure exists for this disease today, there are a number of viable treatment options available to help slow the progression of blindness in those affected, with vascular endothelial growth factor antagonists showing the most efficacy. With more research, funding, and time, it is the goal of scientists to further investigate additional options, including human cell lines, to find a cure for this debilitating disease.","abstract_html":"Age-related macular degeneration is a form of blindness that targets the macula of the eye and causes progressive vision loss. Many individuals all over the world are affected by this disease with the numbers expected to only increase in the coming years. As a result, it is critical that treatment options for this disease continue to be investigated to slow or halt the progression of disease and to hopefully one day find a cure. Currently, there are numerous treatment options available including laser therapy as well as vascular endothelial growth factor antagonists. In addition, there are human cell lines being investigated as possible study tools and future treatment options or cures. Although no cure exists for this disease today, there are a number of viable treatment options available to help slow the progression of blindness in those affected, with vascular endothelial growth factor antagonists showing the most efficacy. With more research, funding, and time, it is the goal of scientists to further investigate additional options, including human cell lines, to find a cure for this debilitating disease.","abstract_has_math":false,"creators":["Marcos, Courtney"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Spencer, Jean L."],"committee_chairs":[],"committee_members":[],"year":2024,"date_issued":"2024","date_published":"2024","updated_at":"2026-11-18T20:18:47Z","subjects":["Ophthalmology","Aging","Medicine","Age-related","Macular degeneration","Neovascular"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/51660","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/51660","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F51660","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Spencer, Jean L."]},{"key":"dc:creator","label":"Author","values":["Marcos, Courtney"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2025-10-27T17:17:38Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2025-10-27T17:17:38Z"]},{"key":"dc:date.issued","label":"Date","values":["2024"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2025-10-27T16:02:10Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Ophthalmology","Aging","Medicine","Age-related","Macular degeneration","Neovascular"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/51660"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2024"]},{"key":"dc:description.abstract","label":"Abstract","values":["Age-related macular degeneration is a form of blindness that targets the macula of the eye and causes progressive vision loss. Many individuals all over the world are affected by this disease with the numbers expected to only increase in the coming years. As a result, it is critical that treatment options for this disease continue to be investigated to slow or halt the progression of disease and to hopefully one day find a cure. Currently, there are numerous treatment options available including laser therapy as well as vascular endothelial growth factor antagonists. In addition, there are human cell lines being investigated as possible study tools and future treatment options or cures. Although no cure exists for this disease today, there are a number of viable treatment options available to help slow the progression of blindness in those affected, with vascular endothelial growth factor antagonists showing the most efficacy. With more research, funding, and time, it is the goal of scientists to further investigate additional options, including human cell lines, to find a cure for this debilitating disease."]},{"key":"dc:title","label":"Title","values":["The pathogenesis, progression, and treatment of neovascular age-related macular degeneration"]}]}],"canonical_facts":{"dc:contributor.advisor":["Spencer, Jean L."],"dc:creator":["Marcos, Courtney"],"dc:date.accessioned":["2025-10-27T17:17:38Z"],"dc:date.available":["2025-10-27T17:17:38Z"],"dc:date.issued":["2024"],"dc:date.updated":["2025-10-27T16:02:10Z"],"dc:description":["2024"],"dc:description.abstract":["Age-related macular degeneration is a form of blindness that targets the macula of the eye and causes progressive vision loss. Many individuals all over the world are affected by this disease with the numbers expected to only increase in the coming years. As a result, it is critical that treatment options for this disease continue to be investigated to slow or halt the progression of disease and to hopefully one day find a cure. Currently, there are numerous treatment options available including laser therapy as well as vascular endothelial growth factor antagonists. In addition, there are human cell lines being investigated as possible study tools and future treatment options or cures. Although no cure exists for this disease today, there are a number of viable treatment options available to help slow the progression of blindness in those affected, with vascular endothelial growth factor antagonists showing the most efficacy. With more research, funding, and time, it is the goal of scientists to further investigate additional options, including human cell lines, to find a cure for this debilitating disease."],"dc:identifier.uri":["https://hdl.handle.net/2144/51660"],"dc:language.iso":["en_US"],"dc:subject":["Ophthalmology","Aging","Medicine","Age-related","Macular degeneration","Neovascular"],"dc:title":["The pathogenesis, progression, and treatment of neovascular age-related macular degeneration"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:18:47Z"}